Comparative Efficacy of Cemiplimab to Historical Standard of Care in France

NCT05302297 · clinicaltrials.gov ↗

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer/Squamous Cell Carcinoma of Skin

Interventions

DRUG: Cemiplimab

Sponsor

Sanofi

Collaborators

[object Object]